Tag: Late Breaking Trial

Posterior Wall Ablation Does Not Help Patients With Persistent Atrial Fibrillation

sarah JonasResearch Alert

FOR IMMEDIATE RELEASE                  Contact:  Ilana Nikravesh                  Mount Sinai Press Office                  212-241-9200                   [email protected]   …

Coronary Bioresorbable Scaffolds Nearly as Safe and Effective as Conventional Metal Stents for Heart Disease Patients

sarah JonasResearch Results

First-generation bioresorbable vascular scaffolds (BVS) may be just as effective as drug-eluting metallic stents, which are currently the standard treatment for heart disease patients undergoing percutaneous coronary intervention (PCI).

High-Dose Anticoagulation Can Reduce Intubations and Improve Survival for Hospitalized COVID-19 Patients

sarah JonasResearch Results

High-dose anticoagulation can reduce deaths by 30 percent and intubations by 25 percent in hospitalized COVID-19 patients who are not critically ill when compared to the standard treatment, which is low-dose anticoagulation.

Transcatheter Mitral Valve Repair in Heart Failure Patients Significantly Reduces Hospitalizations and Improves Survival

sarah JonasResearch Results

Breakthrough findings from study led by Mount Sinai researcher could improve outcomes for high-risk patients

New Risk Score Predicts Mortality for Atrial Fibrillation Patients Undergoing Transcatheter Aortic Valve Replacement

sarah JonasResearch Results

Mount Sinai researchers develop new risk stratification tool to optimize patient care and outcomes after TAVR